| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.940.721 | 11.726.923 | 12.072.887 | 18.355.500 | 15.372.220 | 17.837.321 | 16.710.775 | 21.131.148 | 21.825.132 | 24.588.864 |
| Total Income - EUR | 8.947.353 | 11.730.386 | 12.080.488 | 18.372.793 | 15.397.513 | 19.141.918 | 17.034.233 | 21.325.520 | 22.080.923 | 24.606.116 |
| Total Expenses - EUR | 8.250.096 | 10.797.556 | 11.187.207 | 17.351.836 | 14.828.288 | 18.622.891 | 16.309.767 | 20.544.617 | 21.239.608 | 24.015.450 |
| Gross Profit/Loss - EUR | 697.257 | 932.830 | 893.281 | 1.020.956 | 569.225 | 519.027 | 724.466 | 780.903 | 841.315 | 590.666 |
| Net Profit/Loss - EUR | 601.609 | 806.286 | 772.451 | 880.317 | 489.944 | 462.651 | 627.737 | 691.257 | 733.686 | 509.283 |
| Employees | 51 | 73 | 83 | 107 | 92 | 104 | 107 | 104 | 104 | 112 |
Check the financial reports for the company - Farmavita Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.057.924 | 1.031.013 | 1.075.034 | 1.059.010 | 1.746.088 | 1.703.399 | 1.660.655 | 1.666.424 | 1.612.266 | 1.590.134 |
| Current Assets | 2.032.526 | 4.059.806 | 4.820.523 | 11.205.677 | 6.925.785 | 8.206.445 | 5.938.554 | 8.787.758 | 8.735.844 | 9.091.450 |
| Inventories | 808.814 | 858.136 | 992.334 | 1.327.589 | 1.583.791 | 1.974.992 | 1.985.091 | 2.194.873 | 2.817.326 | 3.069.329 |
| Receivables | 921.007 | 2.430.626 | 3.631.027 | 9.727.257 | 5.080.315 | 6.014.069 | 3.796.526 | 6.300.052 | 5.638.923 | 5.425.375 |
| Cash | 302.705 | 771.044 | 197.162 | 150.831 | 261.679 | 217.384 | 156.938 | 292.833 | 279.595 | 596.746 |
| Shareholders Funds | 666.926 | 870.937 | 836.008 | 942.707 | 551.127 | 522.674 | 686.630 | 760.472 | 806.734 | 583.933 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 2.447.921 | 4.246.689 | 5.099.086 | 11.335.904 | 8.161.615 | 9.453.724 | 6.966.165 | 9.732.262 | 9.530.877 | 10.084.721 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmavita Srl